ArticleJDS communications2025
Nonesterified fatty acids during the dry period and their association with peripartum disorders, culling, and pregnancy in dairy cows.
Article in JDS communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this ambidirectional observational cohort study was to explore how nonesterified fatty acids (NEFA) 22 to 35 d before calving were related to NEFA 1 to 14 d before calving and to determine a threshold that could be used to identify cows at risk of poor postpartum health. We enrolled 855 dairy cows from 46 herds, 362 prospectively and 493 retrospectively. The NEFA concentrations were measured during the far-off period (foNEFA; 3 to 5 wk before calving) and in the close-up period (cuNEFA; up to 2 wk before calving), and postpartum infectious and metabolic disorders, reproduction success, and culling were recorded. Using a split dataset, we (1) determined a threshold maximizing the sum of sensitivity and specificity to identify peripartum conditions by classifying elevated NEFA and (2) assessed the associations between elevated NEFA and altered health and reproduction. The associations were expressed as the odds ratio (OR) and the 95% Bayesian credible interval (BCI). The concentration of foNEFA varied from 60 to 700 µmol/L (median = 149), and a threshold of ≥160 µmol/L was identified. Cows with elevated foNEFA had greater odds to have elevated cuNEFA (OR = 183, 95% BCI = 52.1-458), hyperketonemia (OR = 2.0, 95% BCI = 1.0-3.6), displaced abomasum (OR = 12.3, 95% BCI = 1.6-45.8), metritis (OR = 9.4, 95% BCI = 1.3-36.0), and clinical mastitis (OR = 5.8, 95% BCI = 1.9-12.1) than cows below the threshold. Our results suggest that foNEFA, using a threshold of ≥160 µmol/L, could be used by veterinarians as a monitoring or investigating tool to assess cows' negative energy balance before calving, even earlier than 2 wk prepartum. This monitoring could be used to implement early corrective actions to prevent the effect of negative energy balance on reproduction and peripartum health.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.